0001728955-21-000002.txt : 20211110 0001728955-21-000002.hdr.sgml : 20211110 20211110113148 ACCESSION NUMBER: 0001728955-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211110 DATE AS OF CHANGE: 20211110 EFFECTIVENESS DATE: 20211110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dracen Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001728955 IRS NUMBER: 812597193 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-420647 FILM NUMBER: 211395371 BUSINESS ADDRESS: STREET 1: 780 THIRD AVE. STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 410-659-2777 MAIL ADDRESS: STREET 1: 780 THIRD AVE. STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 D 1 primary_doc.xml X0708 D LIVE 0001728955 Dracen Pharmaceuticals, Inc. 780 THIRD AVE. 18TH FLOOR NEW YORK NY NEW YORK 10017 410-659-2777 DELAWARE None None Corporation true 2016 Thomas M. Estok c/o Dracen Pharmaceuticals, Inc. 780 Third Avenue, 18th Floor New York NY NEW YORK 10017 Executive Officer Director Asher Rubin c/o Dracen Pharmaceuticals, Inc. 780 Third Avenue, 18th Floor New York NY NEW YORK 10017 Executive Officer Drew Pardoll, M.D., Ph.D. c/o Dracen Pharmaceuticals, Inc. 780 Third Avenue, 18th Floor New York NY NEW YORK 10017 Director Jonathan Leff c/o Dracen Pharmaceuticals, Inc. 780 Third Avenue, 18th Floor New York NY NEW YORK 10017 Director Dennis Bilski c/o Dracen Pharmaceuticals, Inc. 780 Third Ave, 18th Floor New York NY NEW YORK 10017 Executive Officer Biotechnology Decline to Disclose 06b false 2021-11-01 false true false 0 17046698 8584398 8462300 false 8 0 0 0 false Dracen Pharmaceuticals, Inc. Dennis Bilski Dennis Bilski Chief Financial Officer 2021-11-09